Salbutamol treatment did not change the level of the SMN protein in SMA patient blood samples, but valproate and phenylbutyrate increased the SMN level in the blood and in skin fibroblast cultures from these patients [126,155,156]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.